Nurse and physician inter-rater agreement of three performance status measures in palliative care outpatients
- 23 July 2009
- journal article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 18 (5) , 609-616
- https://doi.org/10.1007/s00520-009-0700-9
Abstract
Performance status (PS) scales are used widely in oncology practice and research. We compared inter-rater agreement, between nurses and physicians, for three commonly used PS scales. Patients attending an oncology palliative care clinic were assessed by a physician and nurse who blindly completed Eastern Cooperative Oncology Group (ECOG), Karnofsky PS (KPS), and palliative PS (PPS) scales. Patients completed the Edmonton symptom assessment system (ESAS). Inter-rater agreement (weighted kappa) for the 457 patients was 0.67 for the ECOG, 0.74 for the KPS, and 0.72 for the PPS. There was no difference between proportions of physicians’ vs. nurses’ ratings of KPS, >60 vs. ≤60 (McNemar’s test, p = 0.33); however, physicians were more likely to rate patients as having better PS for the ECOG (77% in the 0–2 range vs. 70% for nurses, p = 0.0003) and PPS (63% in the 70–100 range vs. 54% for nurses, p = 0.0001). Physician and nurse scores of ECOG, KPS, and PPS were all correlated with ESAS distress score (Pearson correlation, r = 0.4–0.5). Although inter-rater agreement was good for all three scales, physicians tended to rate patients as healthier for the PPS and ECOG. The KPS may provide greater consistency of PS ratings by different oncology professionals in clinical and research settings.Keywords
This publication has 47 references indexed in Scilit:
- The Terrible Choice: Re-Evaluating Hospice Eligibility Criteria for CancerJournal of Clinical Oncology, 2009
- The palliative performance scale: examining its inter-rater reliability in an outpatient palliative radiation oncology clinicSupportive Care in Cancer, 2008
- A reliability and validity study of the Palliative Performance ScaleBMC Palliative Care, 2008
- Phase II Trial Evaluating the Clinical and Biologic Effects of Bevacizumab in Unresectable Hepatocellular CarcinomaJournal of Clinical Oncology, 2008
- A Prospective Phase II Study of Induction Carboplatin and Vinorelbine followed by Concomitant Topotecan and Accelerated Radiotherapy (ART) in Locally Advanced Non-small Cell Lung Cancer (NSCLC)Journal of Thoracic Oncology, 2007
- Symptom and medication profiles among cancer patients attending a palliative care clinicSupportive Care in Cancer, 2007
- Small-cell lung cancer patients are just ‘a little bit’ tired: response shift and self-presentation in the measurement of fatigueQuality of Life Research, 2007
- The Correlation Among Patients and Health Care Professionals in Assessing Functional Status Using the Karnofsky and Eastern Cooperative Oncology Group Performance Status ScalesSupportive Cancer Therapy, 2004
- High levels of untreated distress and fatigue in cancer patientsBritish Journal of Cancer, 2004
- A Coefficient of Agreement for Nominal ScalesEducational and Psychological Measurement, 1960